Paper213652
Subpopulations of breast carcinoma defined by S-phase fraction, morphology, and estrogen receptor content.
Meyer JS and 2 others. Lab Invest, 1978. Cited by 108 papers, by iCite.
Cite this record
ConductScience Library. Subpopulations of breast carcinoma defined by S-phase fraction, morphology, and estrogen receptor content. Papers, record 213652. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/213652
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Subpopulations of breast carcinoma defined by S-phase fraction, morphology, and estrogen receptor content.
- PubMed
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Receptors, Estrogen | Major topic |
| Adenocarcinoma, Mucinous | |
| Adult | |
| Age Factors | |
| Aged | |
| Axilla | |
| Carcinoma, Papillary | |
| Cell Cycle | |
| Estradiol | |
| Estradiol Congeners | |
| Female | |
| Humans | |
| Lymphatic Metastasis | |
| Male | |
| Menopause | |
| Menstruation | |
| Middle Aged | |
| Neoplasm Metastasis | |
| Receptors, Progesterone |
Source PubMed
Cited by18
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 108 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 7865846 | Thymidine labeling index and Ki-67 growth fraction in breast cancer: comparison and correlation with prognosis. | Breast Cancer Res Treat | 1994 | https://conductscience.org/library/papers/7865846 | PubMed |
| 7459204 | Oestrogen receptors in breast tumours: associations with age, menopausal status and epidemiological and clinical features in 735 patients. | Br J Cancer | 1980 | https://conductscience.org/library/papers/7459204 | PubMed |
| 7348569 | Adjuvant therapy for stage II, estrogen receptor negative breast cancer. | Breast Cancer Res Treat | 1981 | https://conductscience.org/library/papers/7348569 | PubMed |
| 7348564 | Correlation of primary breast cancer histopathology and estrogen receptor content. | Breast Cancer Res Treat | 1981 | https://conductscience.org/library/papers/7348564 | PubMed |
| 6378283 | Practical breast carcinoma cell kinetics: review and update. | Breast Cancer Res Treat | 1984 | https://conductscience.org/library/papers/6378283 | PubMed |
| 6293159 | Oestrogen receptors in human breast cancer. Problems of correlation with histopathological features. | Virchows Arch A Pathol Anat Histol | 1982 | https://conductscience.org/library/papers/6293159 | PubMed |
| 6182164 | Some aspects of the metastatic process. | J Clin Pathol | 1982 | https://conductscience.org/library/papers/6182164 | PubMed |
| 4010096 | Significance of the Tritiated Thymidine Labeling Index in breast cancers. | Jpn J Surg | 1985 | https://conductscience.org/library/papers/4010096 | PubMed |
| 3925207 | Sequential assays of hormone receptors and the Tritiated Thymidine Labeling Index in 7,12-dimethylbenz(a)anthracene-induced rat mammary cancers. | Jpn J Surg | 1985 | https://conductscience.org/library/papers/3925207 | PubMed |
| 3282535 | Carcinoma of the cervix uteri: an assessment of tumour proliferation using the monoclonal antibody Ki67. | Br J Cancer | 1988 | https://conductscience.org/library/papers/3282535 | PubMed |
| 3242648 | Proliferative index of breast carcinoma by thymidine labeling: prognostic power independent of stage, estrogen and progesterone receptors. | Breast Cancer Res Treat | 1988 | https://conductscience.org/library/papers/3242648 | PubMed |
| 3022849 | Cell kinetics of histologic variants of in situ breast carcinoma. | Breast Cancer Res Treat | 1986 | https://conductscience.org/library/papers/3022849 | PubMed |
| 3013349 | Transferrin receptor is inversely correlated with estrogen receptor in breast cancer. | Breast Cancer Res Treat | 1986 | https://conductscience.org/library/papers/3013349 | PubMed |
| 2850408 | [Biological significance of estrogen receptor status in axillary lymph node metastases of invasive ductal breast cancers]. | Klin Wochenschr | 1988 | https://conductscience.org/library/papers/2850408 | PubMed |
| 2817079 | Biological grading of breast cancer using antibodies to proliferating cells and other markers. | Am J Pathol | 1989 | https://conductscience.org/library/papers/2817079 | PubMed |
| 2552652 | Nucleolar grading of breast cancer. Comparative studies on frequency and localization of nucleoli and histology, stage, hormonal receptor status and lectin histochemistry. | Virchows Arch A Pathol Anat Histopathol | 1989 | https://conductscience.org/library/papers/2552652 | PubMed |
| 2536520 | Thymidine labeling index and Ki-67 growth fraction in lesions of the breast. | Am J Pathol | 1989 | https://conductscience.org/library/papers/2536520 | PubMed |
| 1960228 | Prognostic value of morphometry in breast cancer. | J Clin Pathol | 1991 | https://conductscience.org/library/papers/1960228 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ESR1 | 2099 | PubTator's text mining | https://conductscience.org/library/genes/2099 | NCBI Gene |
| PGR | 5241 | PubTator's text mining | https://conductscience.org/library/genes/5241 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/213652
GET https://conductscience.org/api/papers/v1/213652/authors